Sort
23,748 grants matching “melanoma”
Clinical production of viral vectors for cancer gene therapy
$774,679Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Developing new immunotherapies based of CD4+ T cells
$774,677Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Postmortem Pathology
$774,241David E Kleiner · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA
Characterization of Cancer Stem Cells
$774,059William Farrar · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
DEVELOPMENT OF A NANOSECOND PULSED ELECTRIC FIELD SYSTEM TO TREAT SKIN CANCER
$773,914Richard Lee Nuccitelli · Bioelectromed Corporation · R44 · FY2010 · CA
A Targeted Approach to Treat Immunotherapy-Induced Myocarditis with CXCR3 Blockade
$773,843Han Zhu · Stanford University · R01 · FY2025 · HL
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$773,675David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
CCR Confocal Microscopy Core
$773,393Susan Garfield · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
NUTRITIONAL AND BIOCHEMICAL/GENETIC MARKERS OF CANCER
$773,392Brigham And Women'S Hospital · R01 · FY2000 · CA
Building better T cell receptors for targeted immunotherapy
$772,935Brian M Baker · University Of Notre Dame · R01 · FY2017 · AI
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
$772,615John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2017 · CA
DELINEATING NOVEL MOLECULAR PATHWAYS CRITICAL FOR THE GROWTH OF GNAQ/11- MUTANT UVEAL MELANOMA CELLS
$772,480The University Of Iowa · · FY2022 · Department of the Army
DCTD Functional Genomics
$772,455David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2012 · CA
ABC Transporters in Human Disease and Multidrug Resistance
$772,224Michael Dean · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Mechanisms of non-classical multidrug resistance in cancer
$772,117Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$772,064James R. Heath · Institute For Systems Biology · U54 · FY2024 · CA
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$771,133Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Building the foundations of commensal vaccines
$770,910Michael Andrew Fischbach · Stanford University · R01 · FY2023 · AI
Clinical Trials of Immunotherapies for Childhood Cancer
$770,902Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Vaccines and Therapeutics for Anthrax
$770,304Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Using ultrasound and microbubbles to augment antibiotic efficacy against periprosthetic joint infections
$769,390Lauren Jo Delaney · Thomas Jefferson University · R01 · FY2025 · AI
Reducing Skin Cancer Risk in Childhood Cancer Survivors
$769,340Alan C Geller · Harvard School Of Public Health · R01 · FY2013 · CA
CLINICAL TRIALS USING TCR TRANSDUCED T CELL FOR ADOPTIVE IMMUNOTHERAPY
$768,601Michael I Nishimura · Loyola University Chicago · P01 · FY2015 · CA
UNIVERSITY OF PENNSYLVANIA CANCER GENETICS NETWORK
$768,485University Of Pennsylvania · U24 · FY2002 · CA
Growth Factor Imaging
$768,482Peter L. Choyke · Basic Sciences · Z01 · FY2007 · CA